Jci_page_head_homepage_01 Jci_page_head_homepage_02
Weijun Jin, John S. Millar, Uli Broedl, Jane M. Glick, Daniel J. Rader
Published in Volume 111, Issue 3
J Clin Invest. 2003; 111(3):357–362 doi:10.1172/JCI16146
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 3

The clearance of HDL phospholipid from plasma in human apoA-I transgenic mice injected with either anti-mEL or control IgG. Mice (n = 4 mice per group) were injected with either anti-mEL (diamonds) or control IgG (squares). One hour later mice were injected through the tail vein with [3H]methylcholine-DPPC–labeled HDL ([3H]-PC-HDL), and blood samples were obtained over a 6-hour period. Six microliters of plasma taken at each time point were counted, and data are expressed as fractions of the counts at 1 minute.